Skip to main content

Advertisement

SpringerLink
Log in

Disordini ossei metabolici da mutazioni del locus GNAS

  • UNO SGUARDO ALLA STORIA
  • Published:
L'Endocrinologo Aims and scope

An Erratum to this article was published on 18 September 2023

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Change history

Bibliografia

  1. Masi L, Agnusdei D, Bilezikian J et al. (2015) Taxonomy of rare genetic metabolic bone disorders. Osteoporos Int 26:2529–2558

    Article  CAS  PubMed  Google Scholar 

  2. Adegbite NS, Xu M, Kaplan FS et al. (2008) Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification. Am J Med Genet, Part A 146A:1788–1796

    Article  CAS  PubMed  Google Scholar 

  3. Gupta D, Garg P, Mittal A (2017) Computed tomography in craniofacial fibrous dysplasia: a case series with review of literature and classification update. Open Dent J 17(Suppl 1, M7):384–403

    Article  Google Scholar 

  4. Toni R (2017) La displasia fibrosa dell’osso e la sindrome di McCune-Albright. L’Endocrinologo 18:297–300

    Google Scholar 

  5. Monge J, Kricun M, Radovčić J et al. (2013) Fibrous dysplasia in a 120,000+ year old Neandertal from Krapina, Croatia. PLoS ONE 8(6):e64539

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Wells C (1963) Polyostotic fibrous dysplasia in a 7th century Anglo-Saxon. Br J Radiol 36:925–926

    Article  CAS  PubMed  Google Scholar 

  7. Craig E, Craig G (2013) The diagnosis and context of facial deformity from and Anglo-Saxon cemetery of Spofforth, North Yorkshire. Int J Osteoarchaeol 23(6):631–639

    Article  Google Scholar 

  8. Aegerter E (1950) The possible relationship of neurofibromatosis, congenital pseudarthrosis and fibrous dysplasia. J Bone Jt Surg 32A:618–626

    Article  Google Scholar 

  9. Elefteriou F, Kolanczyk M, Schindeler A et al. (2009) Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options. Am J Med Genet, Part A 149A:2327–2338

    Article  CAS  PubMed  Google Scholar 

  10. Von Recklinghausen DF (1891) Die fibrose oder deformierende Ostitis, die Osteomalacie und die osteoplastische Carcinose in ihren gegenseitigen Beziehungen. In: Festschrift Rudolf Virchow zu seinem 71. Geburtstage, Berlin, pp 1–89

    Google Scholar 

  11. McCune DJ (1936) Osteitis fibrosa cystica: the case of a nine year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Transactions Society Ped Res Ann Meeting, May 5, 1936. Am J Dis Child 52:743–747

    Google Scholar 

  12. McCune DJ, Bruch H (1937) Osteodystrophia fibrosa: report of a case in which the condition was combined with precocious puberty, pathologic pigmentation of the skin and hyperthyroidism, with a review of the literature. Am J Dis Child 54:806–848

    Article  Google Scholar 

  13. Albright F, Butler AM, Hampton AO, Smith P (1937) Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation, and endocrine dysfunction, with precocious puberty in females: report of 5 cases. N Engl J Med 216:727–746

    Article  Google Scholar 

  14. Albright F, Scoville B, Sulkowitch HW (1938) Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation, and a gonadal dysfunction. Endocrinology 22:411–421

    Article  Google Scholar 

  15. Weinstein LS, Shenker A, Gejman PV et al. (1991) Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688–1695

    Article  CAS  PubMed  Google Scholar 

  16. Schwinderg WF, Francomano CL, Levine MA (1992) Identification of a mutation in the gene encoding the A subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89:5152–5156

    Article  Google Scholar 

  17. Mantovani G (2011) Pseudohypoparathyroidism: diagnosis and treatment. J Clin Endocrinol Metab 96:3020–3030

    Article  CAS  PubMed  Google Scholar 

  18. Levine MA (2012) An update on the clinical and molecular characteristics of pseudohypoparathyroidism. Curr Opin Endocrinol Diabetes Obes 19:443–451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Mantovani G, Bastepe M, Monk D et al. (2020) Recommendations for diagnosis and treatment of pseudohypoparathyroidism and related disorders: an updated practical tool for physicians and patients. Horm Res Paediatr 93:182–196

    Article  CAS  PubMed  Google Scholar 

  20. Toni R (2013) Fuller Albright e la resistenza al paratormone. L’Endocrinologo 14:176–178

    Google Scholar 

  21. Toni R (2018) Poliuria insipida iperbarica e cuore endocrino. L’Endocrinologo 19:266–269

    Google Scholar 

  22. Toni R, Di Conza G, Barbaro F et al. (2020) Microtopography of immune cells in osteoporosis and bone lesions by endocrine disruptors. Front Immunol 11:1737

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Cary RL, Waddell S, Racioppi L et al. (2013) Inhibition of Ca2+/calmodulin-dependent protein kinase kinase 2 stimulates osteoblast formation and inhibits osteoclast differentiation. J Bone Miner Res 28:1599–1610

    Article  CAS  PubMed  Google Scholar 

  24. Albright F, Forbes AP, Henneman PH (1952) Pseudopseudohypoparathyroidism Trans Assoc Am Physicians 65:337–350

    CAS  PubMed  Google Scholar 

  25. Albright F, Burnett CH, Smith PH, Parson W (1942) Pseudo-hypoparathyroidism – an example of “Seabright-Bantam Syndrome”. Report of three cases. Endocrinology 30:922–932

    CAS  Google Scholar 

  26. Patten JL, Johns DR, Valle D et al. (1990) Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright’s hereditary osteodystrophy. N Engl J Med 322:1412–1419

    Article  CAS  PubMed  Google Scholar 

  27. Kelsey G (2010) Imprinting on chromosome 20: tissue-specific imprinting and imprinting mutations in the GNAS locus. Am J Med Genet, Part C 154C:377–386

    Article  CAS  PubMed  Google Scholar 

  28. Kaplan FS, Shore EM (2000) Progressive osseous heteroplasia. J Bone Miner Res 15:2084–2094

    Article  CAS  PubMed  Google Scholar 

  29. Kaplan FS, Craver R, MacEwen GD et al. (1994) Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow-up of three previously reported cases. J Bone Jt Surg, Am 76:425–436

    Article  CAS  Google Scholar 

  30. Kaplan FS, Hahn GV, Zasloff MA (1994) Heterotopic ossification: two rare forms and what they can teach us. J Am Acad Orthop Surg 2:288–296

    Article  CAS  PubMed  Google Scholar 

Download references

Ringraziamenti

I dati presentati in questo articolo derivano dal Programma di Ricerca congiunto Re.Mo.BIO.S.Lab – DIMEC – UNIPR/Unità OSTEONET Centro Medico Galliera (San Venanzio di Galliera, BO)/Struttura Semplice di Chirurgia del Piede – Clinica Ortopedica e Traumatologica II, IRCCS IOR, Bologna inerente i Disturbi Endocrini-Metabolici dell’Apparato Locomotore.

Author information

Authors and Affiliations

  1. Dipartimento di Medicina e Chirurgia - DIMEC, Università di Parma, Parma, Italia

    Roberto Toni

  2. Accademia delle Scienze dell’Istituto di Bologna, Bologna, Italia

    Roberto Toni

  3. Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center – Tufts University School of Medicine, Boston, MA, USA

    Roberto Toni

  4. Unità OSTEONET, Sezione di Endocrinologia, Metabolismo e Disturbi della Nutrizione, Centro Medico Galliera - DIMEC, San Venanzio di Galliera (BO), Italia

    Roberto Toni

  5. Corso sui Disordini del Sistema Locomotore, Scuola di Specializzazione in Ortopedia e Traumatologia, Università Vita-Salute San Raffaele, Milano, Italia

    Salvatore Mosca

  6. Struttura Semplice di Chirurgia del Piede, Clinica Ortopedica e Traumatologica II, IRCCS IOR, Bologna, Italia

    Silvio Caravelli & Massimiliano Mosca

Authors
  1. Roberto Toni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salvatore Mosca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Silvio Caravelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Massimiliano Mosca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Toni.

Ethics declarations

Conflitto di interesse

Gli autori Roberto Toni, Salvatore Mosca, Francesco Caravelli e Massimiliano Mosca dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Additional information

Proposto da R. Toni.

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

The given name of the third author was given wrongly. It should be “Silvio”.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Toni, R., Mosca, S., Caravelli, S. et al. Disordini ossei metabolici da mutazioni del locus GNAS. L'Endocrinologo 24, 417–422 (2023). https://doi.org/10.1007/s40619-023-01333-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-023-01333-3

Search

Navigation